{"entity":{"type":"insider","cik":"0002049375","url":"/insider/0002049375","json_url":"/insider/0002049375.json","name":"Gaslightwala Abizer","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":7,"n_filings":4,"first":"2025-06-20","last":"2025-08-29","span_basis":"filed_date"},"name_variants":[{"name":"Gaslightwala Abizer","source":"filing","n_filings":4,"first_seen":"2025-06-20","last_seen":"2025-08-29"}],"transactions":[{"id":4635797,"accession":"0001641172-25-026025","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001641172-25-026025","line_url":"/filing/0001641172-25-026025#line-3","is_derivative":false,"issuer_cik":"0001541157","issuer_name":"Akari Therapeutics Plc","issuer_ticker":"AKTX","issuer_name_source":null,"issuer_url":"/issuer/0001541157","owner_cik":"0002049375","owner_name":"Gaslightwala Abizer","owner_display_name":"Gaslightwala Abizer","owner_url":"/insider/0002049375","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"American Depositary Shares representing Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3000.0,"shares_display":"3,000","price_per_share":0.9,"price_display":"0.90","price_state":"stated","total_value":2700.0,"total_display":"2,700.00","total_whole":"2,700","shares_owned_after":298574.0,"shares_owned_after_display":"298,574","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-25","filed_date":"2025-08-29","scope":"insider"},{"id":4635792,"accession":"0001641172-25-026025","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001641172-25-026025","line_url":"/filing/0001641172-25-026025#line-2","is_derivative":false,"issuer_cik":"0001541157","issuer_name":"Akari Therapeutics Plc","issuer_ticker":"AKTX","issuer_name_source":null,"issuer_url":"/issuer/0001541157","owner_cik":"0002049375","owner_name":"Gaslightwala Abizer","owner_display_name":"Gaslightwala Abizer","owner_url":"/insider/0002049375","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"American Depositary Shares representing Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":8000.0,"shares_display":"8,000","price_per_share":0.93,"price_display":"0.93","price_state":"stated","total_value":7440.0,"total_display":"7,440.00","total_whole":"7,440","shares_owned_after":295574.0,"shares_owned_after_display":"295,574","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-22","filed_date":"2025-08-29","scope":"insider"},{"id":4635785,"accession":"0001641172-25-026025","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001641172-25-026025","line_url":"/filing/0001641172-25-026025#line-1","is_derivative":false,"issuer_cik":"0001541157","issuer_name":"Akari Therapeutics Plc","issuer_ticker":"AKTX","issuer_name_source":null,"issuer_url":"/issuer/0001541157","owner_cik":"0002049375","owner_name":"Gaslightwala Abizer","owner_display_name":"Gaslightwala Abizer","owner_url":"/insider/0002049375","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"American Depositary Shares representing Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":0.94,"price_display":"0.94","price_state":"stated","total_value":9400.0,"total_display":"9,400.00","total_whole":"9,400","shares_owned_after":287574.0,"shares_owned_after_display":"287,574","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-21","filed_date":"2025-08-29","scope":"insider"},{"id":5118519,"accession":"0000950170-25-089976","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-25-089976","line_url":"/filing/0000950170-25-089976#line-2","is_derivative":false,"issuer_cik":"0001541157","issuer_name":"Akari Therapeutics Plc","issuer_ticker":"AKTX","issuer_name_source":null,"issuer_url":"/issuer/0001541157","owner_cik":"0002049375","owner_name":"Gaslightwala Abizer","owner_display_name":"Gaslightwala Abizer","owner_url":"/insider/0002049375","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"American Depositary Shares representing Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5203.0,"shares_display":"5,203","price_per_share":1.16,"price_display":"1.16","price_state":"stated","total_value":6035.48,"total_display":"6,035.48","total_whole":"6,035","shares_owned_after":277574.0,"shares_owned_after_display":"277,574","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-06-24","filed_date":"2025-06-25","scope":"insider"},{"id":5118515,"accession":"0000950170-25-089976","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-089976","line_url":"/filing/0000950170-25-089976#line-1","is_derivative":false,"issuer_cik":"0001541157","issuer_name":"Akari Therapeutics Plc","issuer_ticker":"AKTX","issuer_name_source":null,"issuer_url":"/issuer/0001541157","owner_cik":"0002049375","owner_name":"Gaslightwala Abizer","owner_display_name":"Gaslightwala Abizer","owner_url":"/insider/0002049375","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"American Depositary Shares representing Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":943.0,"shares_display":"943","price_per_share":1.15,"price_display":"1.15","price_state":"stated","total_value":1084.45,"total_display":"1,084.45","total_whole":"1,084","shares_owned_after":272371.0,"shares_owned_after_display":"272,371","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-06-23","filed_date":"2025-06-25","scope":"insider"},{"id":5075527,"accession":"0000950170-25-089462","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-089462","line_url":"/filing/0000950170-25-089462#line-1","is_derivative":false,"issuer_cik":"0001541157","issuer_name":"Akari Therapeutics Plc","issuer_ticker":"AKTX","issuer_name_source":null,"issuer_url":"/issuer/0001541157","owner_cik":"0002049375","owner_name":"Gaslightwala Abizer","owner_display_name":"Gaslightwala Abizer","owner_url":"/insider/0002049375","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"American Depositary Shares representing Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":1.2,"price_display":"1.20","price_state":"stated","total_value":12000.0,"total_display":"12,000.00","total_whole":"12,000","shares_owned_after":271428.0,"shares_owned_after_display":"271,428","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-06-20","filed_date":"2025-06-24","scope":"insider"},{"id":4264517,"accession":"0000950170-25-088490","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-088490","line_url":"/filing/0000950170-25-088490#line-1","is_derivative":false,"issuer_cik":"0001541157","issuer_name":"Akari Therapeutics Plc","issuer_ticker":"AKTX","issuer_name_source":null,"issuer_url":"/issuer/0001541157","owner_cik":"0002049375","owner_name":"Gaslightwala Abizer","owner_display_name":"Gaslightwala Abizer","owner_url":"/insider/0002049375","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"American Depositary Shares representing Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15000.0,"shares_display":"15,000","price_per_share":1.2,"price_display":"1.20","price_state":"stated","total_value":18000.0,"total_display":"18,000.00","total_whole":"18,000","shares_owned_after":261428.0,"shares_owned_after_display":"261,428","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-06-17","filed_date":"2025-06-20","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":7,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":7,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":7},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001541157","name":"Akari Therapeutics Plc","url":"/issuer/0001541157","role":"Director, Officer (CEO)","n_filings":4,"first_seen":"2025-06-20","last_seen":"2025-08-29"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0002049375","retrieved_at":"2026-08-24T03:43:23+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}